A national collaborative study was conducted in Japan to evaluate the clini
cal course and the sequelae of patients with hydatidiform mole coexistent w
ith twin live fetus (HMTF). Seventy-two cases of HMTF were diagnosed based
on gross appearance and histopathological criteria. In 18 cases, the molar
parts were cytogenetically confirmed to be of androgenetic origin (complete
mole). The overall incidence of persistent trophoblastic tumour (PTT) in p
atients with HMTF was 30.6%, and it increased to 50.0% in the 18 patients w
ith proven androgenetic complete mole coexistent with twin live fetus (CHMT
F). Among these patients, the mean gestational age at termination of pregna
ncy or delivery in those who developed PTT (n 9) and those who did not(n =
9) were 20.6 and 19.4 weeks respectively. The incidence of severe maternal
complications was significantly higher in patients who subsequently develop
ed PTT (P < 0.05), The rate of subsequent development of PTT in patients wi
th CHMTF was found to be considerably higher than in a previous study of pa
tients with single complete mole (50 and 12.5% respectively). However, sinc
e the risk of malignancy is unchanged with advancement of gestational age,
continued pregnancy may be allowed in patients with HMTF provided that seve
re maternal complications are controlled and fetal karyotype and developmen
t are normal.